Our findings together suggest that UBC13 controls DNMT1 stability via ubiquitination and DNMT1, probably through CHFR and Aurora A, participates in UBC13 regulation of the sensitivity of ovarian cancer cells to paclitaxel. This evidence concerns the gene UBE2N and ovarian carcinoma.